INTRODUCTION: Although depression is common among HIV-positive injection drug users (IDUs), little is known about differences between male and female HIV-positive IDUs. METHODS: We used baseline data for 1126 HIV-positive IDUs from a behavioral intervention trial from 2001 through 2005 in 4 US cities. Using the Brief Symptom Inventory-18, scores indicating high risk for depression were calculated separately for men and women based on raw scores of 9 for women and 7 for men. We did separate logistic regressions for men and women to evaluate correlates of depression in 4 domains: sociodemographic, psychosocial, substance use, and sexual behaviors/attitudes. RESULTS: Approximately one third of women and men met the criteria for being at high risk of depression. Women reported significantly more depressive symptoms than men. Correlates linked with depression for both genders included perceived functional limitation, greater negative feelings regarding condom use, lower social support, and lower sense of empowerment. Being physically abused as adults and being Hispanic were correlates specific to men. No unique correlate was identified for women. DISCUSSION: Because of the high prevalence of depression among HIV-positive IDUs, caregivers should screen HIV-positive IDUs for depression and consider treatment for depression. Because of the similarities in correlates of depression among men and women, case finding and interventions for depression are likely to be similar for male and female HIV-positive IDUs.
INTRODUCTION: Although depression is common among HIV-positive injection drug users (IDUs), little is known about differences between male and female HIV-positive IDUs. METHODS: We used baseline data for 1126 HIV-positive IDUs from a behavioral intervention trial from 2001 through 2005 in 4 US cities. Using the Brief Symptom Inventory-18, scores indicating high risk for depression were calculated separately for men and women based on raw scores of 9 for women and 7 for men. We did separate logistic regressions for men and women to evaluate correlates of depression in 4 domains: sociodemographic, psychosocial, substance use, and sexual behaviors/attitudes. RESULTS: Approximately one third of women and men met the criteria for being at high risk of depression. Women reported significantly more depressive symptoms than men. Correlates linked with depression for both genders included perceived functional limitation, greater negative feelings regarding condom use, lower social support, and lower sense of empowerment. Being physically abused as adults and being Hispanic were correlates specific to men. No unique correlate was identified for women. DISCUSSION: Because of the high prevalence of depression among HIV-positive IDUs, caregivers should screen HIV-positive IDUs for depression and consider treatment for depression. Because of the similarities in correlates of depression among men and women, case finding and interventions for depression are likely to be similar for male and female HIV-positive IDUs.
Authors: Jean B Nachega; Richard E Chaisson; Rene Goliath; Anne Efron; Mohammad A Chaudhary; Malathi Ram; Chelsea Morroni; Hennie Schoeman; Amy R Knowlton; Gary Maartens Journal: AIDS Date: 2010-06-01 Impact factor: 4.177
Authors: E Byrd Quinlivan; Jason Fletcher; Elizabeth A Eastwood; Arthur E Blank; Niko Verdecias; Katya Roytburd Journal: AIDS Patient Care STDS Date: 2015-01 Impact factor: 5.078
Authors: Rupali Kotwal Doshi; Nicholas S Vogenthaler; Sarah Lewis; Allan Rodriguez; Lisa Metsch; Carlos del Rio Journal: AIDS Res Hum Retroviruses Date: 2012-03-02 Impact factor: 2.205
Authors: Deborah L Jones; Drenna Waldrop-Valverde; Peggy Gonzalez; Alison Mack; Adarsh M Kumar; Ray Ownby; Stephen M Weiss; Mahendra Kumar Journal: AIDS Care Date: 2010-02
Authors: Brian Garnet; Mark Beitel; Christopher J Cutter; Jonathan Savant; Skye Peters; Richard S Schottenfeld; Declan T Barry Journal: Pain Med Date: 2010-11-18 Impact factor: 3.750
Authors: Declan T Barry; Mark Beitel; Brian Garnet; Dipa Joshi; Andrew Rosenblum; Richard S Schottenfeld Journal: J Clin Psychiatry Date: 2009-07-14 Impact factor: 4.384